St. Jude Medical June 15th Short Interest Update

St. Jude Medical (NYSE:STJ) reported a rise of 20.5% or 1,334,200 shares in its short interest. The short figure came in at 2.8% of the total floats. The average daily volume of 2,841,108 shares suggests that the days to cover 7,842,847 short positions, as on June 15,2016, will be 3. On May 31,2016, the short interest was 6,508,647 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

St. Jude Medical (NYSE:STJ): The stock opened at $77.26 on Friday but the bulls could not build on the opening and the stock topped out at $77.54 for the day. The stock traded down to $76.84 during the day, due to lack of any buying support eventually closed down at $76.88 with a loss of -2.05% for the day. The stock had closed at $78.49 on the previous day. The total traded volume was 5,390,442 shares.

The company shares have rallied 5.53% from its 1 Year high price. On Jul 21, 2015, the shares registered one year high at $80.84 and the one year low was seen on Feb 11, 2016. The 50-Day Moving Average price is $76.98 and the 200 Day Moving Average price is recorded at $62.48.

Stocks of St. Jude Medical (NYSE:STJ) rallied by 0.58% during the past week but lost 1.66% on a 4-week basis. In the past week, the company has outperformed the S&P 500 by 2.24% and the outperformance has advanced to 1.31% for the last 4 weeks period.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.